ALLMedicine™ Inflammatory Bowel Disease Center

Dec 2nd, 2021 - Etrolizumab, a humanized anti-β7 antibody, has not been studied in children. Here, we evaluate the pharmacokinetics, pharmacodynamics, and safety of etrolizumab in children with inflammatory bowel disease. Patients age 4 to 17 years with moderatel...

Dec 2nd, 2021 - We assessed whether 5-aminosalicylic acid (5-ASA), as treatment for inflammatory bowel disease (IBD), was associated with an increase in hospitalization for coronavirus disease 2019 and adverse in-hospital outcomes. This was a Danish nationwide re...

Dec 2nd, 2021 - Colitis-associated cancer is a major complication of inflammatory bowel disease remaining an important clinical challenge in terms of diagnosis, screening, and prognosis. Inflammation is a driving factor both in inflammatory bowel disease and canc...

Dec 2nd, 2021 - Coproduction of healthcare services by patients and professionals is seen as an increasingly important mechanism to support person-centred care delivery. Coproduction invites a deeper understanding of what persons sometimes called 'patients' bring...

Dec 2nd, 2021 - P003 Meat Consumption and All-Cause Mortality in 5763 Inflammatory Bowel Disease Patients: A Prospective Cohort Study.|2021|Hui C,Tian F,Lintao D,Xuejie C,Yuhao S,|

Aug 22nd, 2021 - Improvements in disease management, as well as endoscopic technology and quality, have dramatically changed the way in which we conceptualize and manage inflammatory bowel disease-related dysplasia over the past 20 years. Based on evolving literat...

Aug 3rd, 2021 - The effectiveness and safety of vaccinations can be altered by immunosuppressive therapies, and perhaps by inflammatory bowel disease (IBD) itself. These recommendations developed by the Canadian Association of Gastroenterology and endorsed by the...

Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. A...

May 12th, 2021 - Despite the current therapeutic options for the treatment of inflammatory bowel disease, surgery is still frequently required in the emergency setting, although the number of cases performed seems to have decreased in recent years. The World Socie...

Mar 18th, 2021 - ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.|2021|Kucharzik T,Ellul P,Greuter T,Rahier JF,Verstockt B,|adverse effects,therapeutic use,complications,drug therapy,immunology,complications...

Dec 2nd, 2021 - Context: Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for sim...

Nov 26th, 2021 - To develop and train a Convolutional Neural Network to detect and characterize disease severity in inflammatory bowel disease during endoscopy. This initiative will inevitably establish a high-quality large image database. Our secondary study aims...

Nov 24th, 2021 - A longitudinal open-label study that will include individuals who will receive the ChAdOx1 nCoV-19 vaccine (AZD1222), in a standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccinati...

Nov 24th, 2021 - This registry study will include volunteer pediatric patients: approximately 2,000 pediatric patients with Crohn's Disease who have been treated with infliximab and approximately 2,000 pediatric patients with Crohn's Disease who have received ther...

Nov 18th, 2021 - This is a retrospective, cross-sectional, and non-interventional study of participants with moderate to severe IBD (UC or CD). The study will have a cross-sectional evaluation on Day 1 to provide the real-world data of disease activity, treatment ...

Nov 15th, 2021 - NEW YORK (Reuters Health) - In patients with inflammatory bowel disease (IBD) who contracted COVID-19 infection, anti-tumor necrosis factor (anti-TNF) therapies were associated with more favorable outcomes than corticosteroids or mesalamine in a s...

Nov 12th, 2021 - Risk for colorectal cancer (CRC) was increased in people who consumed larger amounts of foods friendly to sulfur-metabolizing bacteria, an analysis of the Health Professionals Follow-up Study and Nurses' Health studies suggested. Participants in t...

Nov 10th, 2021 - Transcript: Bradley Monk, MD, FACOG, FACS: We want to do more. The survival, Krish, for the GOG 240 trial was about, 16.5, 17 months? Is that what you said? Krishnansu S. Tewari, MD:The median was 17 months. Bradley Monk, MD, FACOG, FACS: T...

Nov 9th, 2021 - NEW YORK (Reuters Health) - Assisted reproductive therapy (ART) is safe in women with inflammatory bowel disease (IBD), with outcomes likely similar in women with ulcerative colitis (UC) and medically managed Crohn's disease (CD) compared with the...

Nov 5th, 2021 - LAS VEGAS — Clinical trials of treatments for inflammatory bowel disease (IBD) have disproportionately enrolled White people, researchers say. These skewed demographics could result in researchers overlooking differences in how the disease and its...